Brief: Omnicell Q3 Revenue USD 282 Million Vs. IBES Estimate USD 280.4 Million
30/10/2024 10:30
Oct 30 (Reuters) - Omnicell Q3 adjusted EBITDA USD 39 million vs. IBES estimate USD 32.4 million. * Q3 adjusted net income USD 26 million vs. IBES estimate USD 19.5 million * Q3 net income USD 9 million * outlook FY adjusted EBITDA USD 129-134 million * outlook Q4 adjusted EBITDA USD 40-45 million
Recent news on Omnicell
See all newsCorrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Omnicell Inc reports results for the quarter ended June 30 - Earnings Summary
Omnicell Q2 adjusted EPS beats estimates, but tightens 2026 revenue guidance
Brief: Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry As Senior Vice President
Omnicell Q1 adjusted EPS beats helped by connected devices demand, raises FY outlook